GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                                                                Synonyms: RP 57669 | RP-57669 | RP57669 | Synercid® (dalfopristin + quinupristin)
                                 quinupristin is an approved drug (FDA (1999)) Compound class: 
                                                            Synthetic organic
                                 
                                    
                                        Comment: Quinupristin is a semi-synthetic derivative of streptogramin B. It inhibits the late stage of protein synthesis by binding to the bacterial  50S ribosomal subunit.
                                    
                                 | 
 | |||||||||||||||||||||||||||||||||||
| No information available. | 
| Summary of Clinical Use  | 
| Quinupristin is intravenously administered in fixed combination with dalfopristin to treat severe bacterial infections due to susceptible organisms including methicillin resistant Staphylococcus aureus (MRSA) or Streptococcus pyogenes. | 
| External links  | 
| For extended ADME data see the following: Drugs.com |